Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 43 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August 28, 2026 – Zealand Pharma...
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
GlobeNewswire, Inc.
DUBLIN and BRIDGEWATER, N.J., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today highlighted a new post hoc analysis from the landmark...
Zealand Pharma – Notification of holding of treasury shares
GlobeNewswire, Inc.
Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
GlobeNewswire, Inc.
Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Food as Medicine Market to Reach USD 400.81 Billion by 2031, Growing at a CAGR of 9.5% — MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL , Aug. 24, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ estimates the global food as medicine Industry to grow from USD 254.15 billion in 2026 to USD 400.81 billion by 2031, registering a CAGR of 9.5% during the forecast period....
A New Framework Establishes 'The Hallmarks of Skeletal Muscle Health'
EIN Presswire
An international consortium of experts outlines a unifying conceptual framework to transform precision diagnostics, therapeutics, and healthy aging strategies TORONTO, CANADA, August 20, 2026 /EINPresswire.com/ -- Today, an international team of...
Defending the “High North”, Exercise Northern Viking 2026 kicks off in Iceland
DVIDS - Georgia
U.S. Air Forces in Europe – Air Forces Africa Airmen and aircraft are joining Icelandic Coast Guard, North Atlantic Treaty Organization forces, and U.S. Joint forces in Iceland for the start of U.S. Sixth Fleet’s Northern Viking 2026 (NV26), Aug....
UNCF Announces Historic $12 Million Gift from The James and Judith K. Dimon Foundation to Strengthen HBCU Endowments and Expand Pathways in Healthcare and Education
GlobeNewswire, Inc.
Washington, DC, Aug. 20, 2026 (GLOBE NEWSWIRE) -- UNCF announced The Dimon Fund to Advance Economic Opportunity, a historic $12 million gift from The James and Judith K. Dimon Foundation to strengthen the long-term sustainability of historically...
Dental Insurance Market to reach USD 402.0 Million by 2035 at 6.22% CAGR
EIN Presswire
Dental Insurance Market to Surge from USD 219.8 Million in 2021 to USD 402.0 Million by 2035— By Increasing Oral Health Awareness, Rising Dental Care Costs NY, CA, UNITED STATES, August 27, 2026 /EINPresswire.com/ -- As per Market Research...
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
GlobeNewswire, Inc.
Company announcement No. 40 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Zealand Pharma Announces Financial Results for the First Half of 2026
GlobeNewswire, Inc.
Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all fronts of...
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
GlobeNewswire, Inc.
Company announcement – No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its...
Ascendis Pharma Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
– Q2 2026 product revenue of €315 million (+105% Y/Y), comprising €252 million for YORVIPATH®, €55 million for SKYTROFA®, and €8 million for YUVIWEL® – Through July 31, more than 220 unique YUVIWEL patient enrollments in the U.S. – Substantial...
CIP and Thylander start construction of energy-integrated data centre in Denmark backed by PensionDanmark
GlobeNewswire, Inc.
One of the first major data centres to be wholly owned and operated by Danish companies is now being established in Esbjerg, in southern Denmark.
Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
GlobeNewswire, Inc.
COPENHAGEN, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious Diseases https://doi.org/10.1093/cid/ciag446 describing the use of SNIPR001 in a...
Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)
GlobeNewswire, Inc.
Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Rinn Pharma & Biopharma Expands European Research Collaboration Through NordicPharmaTrain Partnership
EIN Presswire
Rinn Pharma & Biopharma expanding collaborative research and training across the Nordic and European innovation landscape.
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
GlobeNewswire, Inc.
Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
GlobeNewswire, Inc.
Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027 NDA resubmission activities for ZYNQUISTA® in type 1 diabetes nearing completion Phase 1 clinical development of LX9851 ongoing by Novo Nordisk Conference call and...
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
GlobeNewswire, Inc.
Early Outcomes Reinforce the Consistency and Reproducibility of Tanruprubart Treatment Effect Previously Demonstrated in Phase 3 and Real-World Evidence Studies Potential to Become the First Approved Targeted Therapy to Treat GBS Worldwide,...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.